Induction of dopamine D1 and D5 receptors in R28 cells by light exposures

Induction of dopamine D1 and D5 receptors in R28 cells by light exposures

Accepted Manuscript Induction of dopamine D1 and D5 receptors in R28 cells by light exposures Yan Ke, Wentao Li, Zhiqun Tan, Zhikuan Yang PII: S0006-...

5MB Sizes 0 Downloads 61 Views

Accepted Manuscript Induction of dopamine D1 and D5 receptors in R28 cells by light exposures Yan Ke, Wentao Li, Zhiqun Tan, Zhikuan Yang PII:

S0006-291X(17)30565-X

DOI:

10.1016/j.bbrc.2017.03.099

Reference:

YBBRC 37486

To appear in:

Biochemical and Biophysical Research Communications

Received Date: 1 March 2017 Accepted Date: 19 March 2017

Please cite this article as: Y. Ke, W. Li, Z. Tan, Z. Yang, Induction of dopamine D1 and D5 receptors in R28 cells by light exposures, Biochemical and Biophysical Research Communications (2017), doi: 10.1016/j.bbrc.2017.03.099. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT

Induction of dopamine D1 and D5 receptors in R28 cells by light exposures Yan Kea, b,1, Wentao Lia, b, c,1, Zhiqun Tanb,*, Zhikuan Yanga,* Aier School of Ophthalmology, Central South University, Changsha, Hunan Province,

RI PT

a

China b

Institute for Memory Impairments and Neurological Disorders, University of California,

Huizhou No.3 People's Hospital, Guangzhou Medical University, Huizhou, Guangdong

Province, China 1

M AN U

c

SC

Irvine, CA 92697, USA

These two authors contributed equally.

*: corresponding authors:

TE D

Dr. Zhiqun Tan

UCI MIND, 835 Health Science Road, 140 Irvine Hall, Irvine, CA 92697-1280 Tel: +1 949-8241669; Email: [email protected]

EP

Prof. Zhikuan Yang

AC C

Aier Eye Hospital Group, 198 New Century Building, Furong Middle Road, Changsha 41000, China

Tel: +86 13380071988; Email: [email protected]

ACCEPTED MANUSCRIPT

ABSTRACT Dopamine is known to play an important role in the pathophysiological process of myopia development relevant to the ambient lighting, but it is still poorly understood

RI PT

about how lighting regulates dopamine and its interaction with dopamine receptors to mediate the pathogenic signal transduction leading to alterations of ocular globe and the pathogenesis of myopia. Many studies have highlighted changes of ocular dopamine

SC

amount in response to different lighting conditions, but little attention has been paid to the dopamine receptors during these processes. Here we examined the effects of

M AN U

different lighting exposures on the expression of dopamine receptors in rat R28 retinal precursor cells. R28 cells normally grown in dark were exposed to a low (10 lux) or high (500 lux) intensity of a source of LED white light (5000 K~6000 K) for 12 h and total RNA was isolated either immediately or after certain time continuous growing in dark.

TE D

Both conventional and real-time RT-PCR were performed to determine the expression of all five different dopamine receptors in cells after treatments. While the transcripts of dopamine D2, D3, and D4 receptors were not detected in the total RNA preparations of

EP

all the cells, those of D1 and D5 receptors (DRD1 and DRD5) were induced by lighting in contrast to the dark control. Elevated levels of DRD1 and DRD5 mRNA returned back

AC C

close to the original levels once the cells were maintained in dark after light exposures. Immunofluorescence microscopy using a specific antibody confirmed an increase in the immunoreactivity of DRD1 in the cells exposed to 500 lux lighting versus dark control. Notably, treatments of R28 cells with nanomolar dosages of dopamine (0~500 nM) directly downregulated expression of both DRD1 and DRD5, whereas haloperidol (0~50 nM), a DRD1 antagonist, significantly induced expression of DRD1. These results

ACCEPTED MANUSCRIPT

suggest that dopamine receptors in the retinal cells might actively respond to the environmental lighting to act as an important player in the activation of the dopaminergic system in the ocular structures relevant to the lighting-induced pathogenic development

RI PT

of myopia.

Highlights

Dopamine receptors (DRD1 and DRD5) are expressed in R28 cells.



Expression of DRD1 and DRD5 in R28 cells is induced by ambient lighting, but not

SC





M AN U

dopamine.

Expression of DRD1 in R28 cells is also upregulated by haloperidol.

Chemical compounds

TE D

Keywords: dopamine receptors; R28 cells; ambient lighting.

Abbreviations

EP

Dopamine (PubChem CID: 681); Haloperidol (PubChem CID: 3559)

AC C

LED, light emitting diode; PCR, polymerase chain reaction; RT-PCR, reverse transcription - polymerase chain reaction; qPCR, quantitative polymerase chain reaction; DRD1, dopamine receptor D1; DRD2, dopamine receptor D2; DRD3, dopamine receptor D3; DRD4, dopamine receptor D4; DRD5, dopamine receptor D5; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; CT, cycle threshold; DMEM, Dulbecco’s modified Eagle’s medium; DMSO, dimethyl sulfoxide; PBS, phosphate-

ACCEPTED MANUSCRIPT

buffered solution; DAPI, 4',6-diamidino-2-phenylindole; WGA, wheat germ agglutinin; FITC, fluorescein isothiocyanate.

RI PT

Acknowledgements This study was supported by the Science Research Foundation of Aier Eye Hospital Group [Grant No. 201301]. We thank Dr. Gail M. Seigel for generously granting us the permission to use R28 cells, which were kindly provided by

AC C

EP

TE D

M AN U

SC

Dr. Ping Bu.

ACCEPTED MANUSCRIPT

1. Introduction Myopia, also called nearsightedness or short-sightedness is the most common vision

RI PT

disorder affecting approximately over two thirds of the population in most Asian countries or districts [1]. Poor lighting has been known as an important risk factor for the development of nearsightedness in juniors [2,3]. Evidence-based studies demonstrate that outdoor activities significantly reduce the prevalence of myopia and slow down its

SC

progression in children [4,5,6], and ambient outdoor lighting shows protective effects on

M AN U

the development of myopia in animal models [7,8]. Growing studies have highlighted a role of dopamine in the pathogenic development of myopia [9]. While levels of dopamine and related metabolites exhibit a pattern of diurnal-nocturnal changes in the retina [10,11], lighting is the major factor regulating these light/dark cycle-dependent alterations [12,13]. Changes of intraocular dopamine are further linked to the growth

TE D

rhythm of the eye in animal studies [14,15]. Compared with the low vision light environment, appropriate outdoor lighting induces a higher level of dopamine in the retina and blocks deprivation myopia [14,15,16]. When artificial refractive errors were

EP

induced in animal models by lenses, high levels of bright illuminance reduced the

AC C

compensation rate for negative lenses and enhanced the rate of positive lenses, these effects were blocked by a dopamine antagonist [17,18]. These observations further suggest that light-induced myopia development might be mediated, at least in part, by dopamine-dopamine receptor(s)-directed activities. In fact, dopamine is known to function through its receptors, a family of five different types, which are divided into two groups, the excitatory type of D1-class (DRD1 and DRD5) and the inhibitory type of D2class (DRD2, DRD3, and DRD4) [19]. Studies have found that, except for DRD3, all the

ACCEPTED MANUSCRIPT

other four different types of receptors differentially express in the mammalian retina [20]. Molecular genetic analysis and pharmacological experiments reveal that increased dopamine-induced activation of dopamine D2 receptor promotes ocular axis growth to

RI PT

contribute to the development of myopia. In contrast, activation of D1 receptor by the increase of dopamine generates a stop signal to suppress axial growth once the eye has reached emmetropization [4,21,22,23]. Nevertheless, it is still poorly known that

SC

how the expression of dopamine receptors coordinates with dopamine in the retinal cells in response to ambient lighting to mediate signal transduction leading to the

M AN U

pathogenic development of myopia. To determine whether the ambient lighting directly affects expression of dopamine receptors in ocular cells, we employed both conventional and real-time quantitative PCR (qPCR) to examine the expression of all five different types of dopamine receptors in rat R28 cells exposed to the different

TE D

lighting conditions. The results suggest that ambient lighting might directly regulate expression of dopamine receptors by which contributes to the activation of the dopaminergic pathway in ocular cells.

AC C

2.1 Reagents

EP

2. Materials and methods

Dulbecco’s modified Eagle’s medium (DMEM), heat-inactivated fetal bovine serum, PenStrep, TrypLe, Trizol Reagent, High-Capacity cDNA Reverse Transcription Kit, Alexa Fluor 594-conjugated goat anti-rabbit secondary antibody, Hoechst 33342 and fluorescent

wheat

germ

agglutinin

(WGA)

were

purchased

from

Invitrogen/ThermoFisher Scientific (Waltham, MA, USA). DNase I, dopamine (H8502),

ACCEPTED MANUSCRIPT

and haloperidol (PHR1724) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Quick-RNA MiniPrep was obtained from Zymo Research (Irvine, CA, USA). Taq 2x Master Mix was purchased from New England Biolabs (Ipswich, MA, USA). 2x SsoFast

RI PT

EvaGreen Supermix was purchased from Bio-Rad (Bio-Rad, Hercules, CA, USA). Rabbit polyclonal antibody against carboxyl terminus of DRD1 was obtained from Santa Cruz Biotechnology (Dallas, TX, USA). Vectashield mounting medium was purchased

M AN U

DNA Technologies (Coralville, IA, USA).

SC

from Vector Laboratories (Burlingame, CA, USA). All primers were synthesized by IDT

2.2 Cells and treatments

The R28 retinal precursor cell line that was originally immortalized from postnatal day 6 Sprague-Dawley rat retina was used for the experiments [24]. Cells were grown in high

TE D

glucose DMEM supplemented with heat-inactivated 10% fetal bovine serum and 1% PenStrep in a humidified atmosphere of 95% air and 5% CO2 at 37 °C. Medium was changed every other day and cells were replated after dissociation with 1xTrypLe as far

EP

as they reached about 95%~100% confluence (about every 3 or 4 days after plating). Cell passages within 10-20 were used for the experiments. To examine the effects of

AC C

light exposures on cells, R28 cells in log-phase growth were first replated into 10 cm plates at about 60%~70% confluence. About 24 h after replating culture media were replaced with fresh medium and cells were placed in the same culture condition with extra lighting at either 10 lux or 500 lux intensity. Cells were either immediately harvested or continuously grow without lighting for another 12 or 24 h prior to harvest for total RNA isolation. The light was provided by a LED bulb which emits pure white light (5000K~6000K, 3W, CS Power Corp., CA, USA). The light intensity around the

ACCEPTED MANUSCRIPT

surface of cell culture medium was calibrated by a digital luxmeter (Dr. Meter DMLX1330B). Considering the potential possibility of lighting-induced changes of ingredients in the culture medium, which might directly affect expression of genes of

RI PT

interest, culture medium that was pre-exposed to 12 h corresponding lighting was used for dark control.

For drug treatments, dopamine and haloperidol were dissolved in distilled water and

SC

dimethyl sulfoxide (DMSO), respectively, to make micromolar scale stock solution, then

M AN U

1~2 µl stock solution was directly added into cell culture medium to obtain the final concentrations as indicated. Equal volume of the solvent was used as vehicle control. All cells were harvested for total RNA isolation 12 h after treatments. 2.3 RNA isolation and synthesis of cDNA

TE D

Total RNA was isolated using either Invitrogen Trizol Reagent or Quick-RNA MiniPrep according to the manufacturers’ instruction or as previously described [25]. Prepared total RNA was further treated with DNase I to remove possible DNA contamination.

EP

Total RNA (2µg) was used for reverse transcription to make cDNA using the HighCapacity cDNA Reverse Transcription Kit following the manufacturer’s manual. The

AC C

reaction was terminated by adding 200 µl TE buffer (10 mM Tris-HCl, 1mM EDTA, pH7.4).

2.4 PCR analysis

Conventional PCR was conducted as previously described [25]. Briefly, each PCR reaction was done with 5µl diluted cDNA mixture, 400 nM each primer, and 25µl Taq 2x Master Mix in a final volume of 50µl followed by agarose gel electrophoresis analysis.

ACCEPTED MANUSCRIPT

The detailed information for the specific primers and related PCR amplification conditions were listed in Table 1. PCR using primers for rat GAPDH was simultaneously performed and the results were used as a cDNA loading control. Rat brain (cortex)

RI PT

derived cDNA was used as a positive control for all five different receptors.

Real-time qPCR was performed as previously described with a minor modification [26]. Each qPCR reaction (20 µl) included diluted cDNA (about 50 ng), 2x SsoFast EvaGreen

(antisense)

TGTGTATCATCAGCGTGGACCGTT-3’

ATTGAGTTGGACCGGGATGAAGGA-3’ AGGTGACCGCATCTTCTTGT-3’

for

DRD1

M AN U

GGGCAGAGTCTGTAGCATCC-3’

SC

Supermix (10 µl), and primers: 5’-CCTTCGATGTGTTTGTGTGG-3’ (sense) and 5’-

(sense)

(antisense)

(sense)

and

for

[27],

or

and DRD5

[28],

5’5’-

or

5’-

5’-CTTGACTGTGCCGTTGAACT-3’

(antisense) for GAPDH [29]. The PCR reactions were subjected to 40 cycles (95℃ × 5

TE D

s, 60℃ × 5 s) in a C1000 Thermal Cycler (Bio-Rad), and results were analyzed by CFX384 Real-Time System (Bio-Rad, USA). Each sample was run in triplicate. The specificity of qPCR reaction was validated by both melting curve analysis and agarose

EP

gel resolution of PCR products as described [26]. Once the number of cycle threshold

AC C

(CT) was determined for each gene by the qPCR system, the relative abundance of the interest genes versus the internal control of GAPDH was depicted by ∆CT, which is calculated from CTinterest - CTGAPDH [26,30]. 2.5 Immunofluorescence microscopy For immunofluorescence, cells were grown on laminin-coated coverslips and treated as same as these grown in the plates. After the treatments (light exposures) both treated

ACCEPTED MANUSCRIPT

and control cells were rinsed with pre-chilled 1x phosphate-buffered solution (PBS, pH7.4) once and fixed in 4% paraformaldehyde 1xPBS for 10 min on ice. Prior to antibody incubation, fixed cells on coverslips were rinsed with 1xPBS and blocked with

RI PT

a blocking buffer as previously described [31]. Then cells were incubated with a specific rabbit polyclonal antibody against carboxyl terminus of DRD1 (H-109, 1:20 in 1xPBS) over night at 4 ℃ followed by 1xPBS wash, and further staining with fluorescent wheat

SC

germ agglutinin (Alexa Fluor 488-conjugated, 1:500 in 1xPBS) Alexa Fluor 594conjugated goat anti-rabbit secondary antibody (Invitrogen, 1:1000 in 1xPBS), and

M AN U

Hoechst 33342 (1:1000 in 1xPBS) for 40 min. Stained cells were coverslipped with Vectashield mounting medium after wash with 1xPBS (5 min x 3) for fluorescence microscopic examination under a Leica DM6B fluorescence microscope attached with

2.6 Data analysis

TE D

SPOT Insight CCD camera.

All experiments were repeated independently at least 3 times. PCR gel pixel intensity

EP

was quantified by GelQuantNet program (www.gelquant-net.com). The data are depicted as the mean ± S.E.M. from three to six independent experiments. Statistical

AC C

analysis was performed by one-way ANOVA analysis followed by Bonferroni test on SPSS Statistics 24. A p-value < 0.05 was considered to be statistically significant. 3. Results

3.1 Light exposures induce expression of DRD1 and DRD5 in R28 cells To examine possible effects of ambient lighting on the expression of dopamine receptors in R28 cells, we first conducted conventional RT-PCR to screen the

ACCEPTED MANUSCRIPT

transcripts of all the five receptors using specific primer sets (Table 1). The schematic diagrams in Fig.1A (left) show the relative target positions of each primer on the sequences of genes or cDNA. The results demonstrate no signal detected for all five

RI PT

receptors in all the cells which were grown in dark without lighting during the experiment, while the positive controls and GAPDH show all predicted band(s) for each gene and no genomic DNA signal, respectively. In contrast, increased expression of

SC

both DRD1 and DRD5 is noticeable in cells directly related to light intensity after 12 h lighting, whereas there is still no change with that of the D2-class receptors (DRD2,

M AN U

DRD3, and DRD4) in response to lighting. Detection of DRD1 and DRD5 signal was further confirmed by qPCR melting curves followed by agarose gel electrophoresis and quantification as shown in Fig. 1B and Fig. 3B, respectively. Moreover, the induction of DRD1 transcript in R28 cells by lighting was also corroborated by the increased

TE D

immunoreactivity of DRD1 protein in both membrane and cytoplasmic compartments in contrast to DAPI-stained nuclei and FITC-WGA-labeled membrane structures as visualized by immunofluorescence microscopy following immunostaining using DRD1

EP

specific H-109 antibody and counterstaining (Fig.2).

AC C

Following detection of DRD1 and DRD5 induction in R28 cells by lighting, we next examined whether elevated expression of both transcripts returned to the basal levels in dark after lighting exposures. Accordingly, cells were maintained in another 12 h or 24 h in dark prior to RNA isolation after 12 h lighting as shown in Fig. 3A. RT-qPCR results revealed that elevated expression of DRD1 and DRD5 by 12 h lighting gradually declined and returned to the point very close to their original basal levels within a 24 h period (Fig. 3B).

ACCEPTED MANUSCRIPT

3.2 Dopamine and its antagonist differentially affects expression of dopamine receptors As ambient lighting is associated with elevation of dopamine in the eyes, we next

RI PT

sought to determine whether dopamine or its antagonist directly modifies expression of DRD1 and DRD5 in R28 cells. R28 cells grown in a dark environment in a regular culture incubator were treated with nanomolar scale dopamine or its antagonist haloperidol for 12 h followed by RNA isolation for qRT-PCR analysis. The results

SC

demonstrate a significant decrease in abundance of both DRD1 and DRD5 transcripts

M AN U

in R28 cells treated with 50nM~500nM dopamine (Fig. 4A). In contrast, 10nM~50nM haloperidol treatments enhanced DRD1 expression about 20% (Fig. 4B). 4. Discussion

As a part of the central nervous system, the retina is known to express all the dopamine

TE D

receptors except for DRD3 in mammals [20]. Although R28 cells were originally derived from the retina of an immature rat, there is only one report about the detection of DRD3 mRNA from a microarray-based gene expression profiling study [24]. Thus, it is still

EP

unclear whether R28 cells express any dopamine receptor(s). The results shown here indicate a low-level expression of the D1-class receptors, i.e., DRD1 and DRD5, in

AC C

these cells. Furthermore, the ambient lighting directly regulates the expression of these two receptors in these cells and the exchange of darkness and light in the environment mediates corresponding cyclic changes in the abundance of expression. A large body of experimental evidence supports an important role of the dopaminergic activation in the control of eye growth and the pathogenic development of myopia [6,9,23]. Changes in expression of dopamine receptors in cells could be part of the accommodative response

ACCEPTED MANUSCRIPT

to the ambient lighting conditions thereby to regulate the dopaminergic activity. Interestingly, when treated with nanomolar scale dopamine, the expression of both DRD1 and DRD5 was inhibited perhaps due to the saturation of occupancy of the

RI PT

receptors by added dopamine. These dosages are close to the range of physiological concentrations of dopamine in the extracellular environment in the retina [13,32]. Thus, further studies are warranted to examine whether the dopamine receptors are still

SC

upregulated in the retina when bright light induces an increase in intraocular dopamine

M AN U

amount in animal models.

Compared to a poor ambient lighting environment, the bright natural outdoor lighting results in higher levels of intraocular dopamine and/or is associated with a lower risk for the development of myopia [4,9]. Our results from R28 cells suggest that ambient lighting directly regulate the expression dopamine receptors in addition to the alteration

TE D

of local dopamine levels. Recent findings from molecular biology analyses reveal that activation of DRD2 is critical for the development of myopia, as genetic or pharmacological silencing of DRD2 attenuates the development of form-deprivation

EP

myopia in mouse [21], whereas pharmacological manipulation of DRD1 activity results

AC C

in opposite effects on the eye growth in guinea pig [22]. Although D2-class dopamine receptors were not detected in these cells, cells treated with haloperidol, a D2-class receptor antagonist, appeared slightly increased expression of DRD1. In addition, a previous study reported expression of DRD3 in R28 cells [24], but we failed to detect DRD3 transcripts in these cells. Our observations appear consistent with the results from the retina [20]. This discrepancy might result from the variation of PCR primers

ACCEPTED MANUSCRIPT

and/or the presence of alternative splicing of DRD3 transcripts in R28 cells leading to the observation in the previous study [24].

RI PT

In summary, our findings indicate expression of dopamine D1 and D5 receptors in the rat R28 retinal precursor cell line. Ambient lighting conditions significantly regulate levels of expression of dopamine receptors in R28 cells. These observations suggest that changes in expression of dopamine receptors might also occur in the retina in

SC

response to the environmental lighting in vivo to contribute to the dopamine-related

M AN U

signal transduction in the eye. Nevertheless, further studies are needed to extend these findings. Disclosure Statement

References

TE D

The authors declare no conflict of interest.

EP

[1] M.J. Smith, J.J. Walline, Controlling myopia progression in children and adolescents, Adolesc Health Med Ther 6 (2015) 133-140.

AC C

[2] J. Gwiazda, E. Ong, R. Held, F. Thorn, Myopia and ambient night-time lighting, Nature 404 (2000) 144.

[3] S.M. Saw, A synopsis of the prevalence rates and environmental risk factors for myopia, Clin Exp Optom 86 (2003) 289-294.

[4] A.N. French, R.S. Ashby, I.G. Morgan, K.A. Rose, Time outdoors and the prevention of myopia, Exp Eye Res 114 (2013) 58-68.

ACCEPTED MANUSCRIPT

[5] M. He, F. Xiang, Y. Zeng, J. Mai, Q. Chen, J. Zhang, W. Smith, K. Rose, I.G. Morgan, Effect of Time Spent Outdoors at School on the Development of Myopia

1148.

RI PT

Among Children in China: A Randomized Clinical Trial, JAMA 314 (2015) 1142-

[6] T.T. Norton, J.T. Siegwart, Jr., Light levels, refractive development, and myopia--a speculative review, Exp Eye Res 114 (2013) 48-57.

SC

[7] T.T. Norton, What Do Animal Studies Tell Us about the Mechanism of MyopiaProtection by Light?, Optom Vis Sci 93 (2016) 1049-1051.

M AN U

[8] Y. Wang, H. Ding, W.K. Stell, L. Liu, S. Li, H. Liu, X. Zhong, Exposure to sunlight reduces the risk of myopia in rhesus monkeys, PLoS One 10 (2015) e0127863. [9] M. Feldkaemper, F. Schaeffel, An updated view on the role of dopamine in myopia, Exp Eye Res 114 (2013) 106-119.

TE D

[10] P.L. Megaw, M.G. Boelen, I.G. Morgan, M.K. Boelen, Diurnal patterns of dopamine release in chicken retina, Neurochem Int 48 (2006) 17-23. [11] I. Nir, R. Haque, P.M. Iuvone, Diurnal metabolism of dopamine in the mouse retina,

EP

Brain Res 870 (2000) 118-125.

[12] J.Z. Nowak, E. Zurawska, Dopamine in the rabbit retina and striatum: diurnal

AC C

rhythm and effect of light stimulation, J Neural Transm 75 (1989) 201-212.

[13] N.V. Pozdeyev, E.V. Lavrikova, Diurnal changes of tyrosine, dopamine, and dopamine metabolites content in the retina of rats maintained at different lighting conditions, J Mol Neurosci 15 (2000) 1-9.

[14] D.L. Nickla, Ocular diurnal rhythms and eye growth regulation: where we are 50 years after Lauber, Exp Eye Res 114 (2013) 25-34.

ACCEPTED MANUSCRIPT

[15] S. Weiss, F. Schaeffel, Diurnal growth rhythms in the chicken eye: relation to myopia development and retinal dopamine levels, J Comp Physiol A 172 (1993) 263-270.

RI PT

[16] T.L. Richard A. Stone, Alan M. Laties, P. Michael Iuvone, Retinal dopamine and form-deprivation myopia, Proc Natl Acad Sci U S A 86 (1989) 704-706.

[17] R. Ashby, A. Ohlendorf, F. Schaeffel, The effect of ambient illuminance on the

SC

development of deprivation myopia in chicks, Invest Ophthalmol Vis Sci 50 (2009) 5348-5354.

M AN U

[18] R.S. Ashby, F. Schaeffel, The effect of bright light on lens compensation in chicks, Invest Ophthalmol Vis Sci 51 (2010) 5247-5253.

[19] J.M. Beaulieu, R.R. Gainetdinov, The physiology, signaling, and pharmacology of dopamine receptors, Pharmacol Rev 63 (2011) 182-217.

TE D

[20] J. Nguyen-Legros, C. Versaux-Botteri, P. Vernier, Dopamine receptor localization in the mammalian retina, Mol Neurobiol 19 (1999) 181-204. [21] F. Huang, T. Yan, F. Shi, J. An, R. Xie, F. Zheng, Y. Li, J. Chen, J. Qu, X. Zhou,

EP

Activation of dopamine D2 receptor is critical for the development of formdeprivation myopia in the C57BL/6 mouse, Invest Ophthalmol Vis Sci 55 (2014)

AC C

5537-5544.

[22] L. Jiang, K. Long, F. Schaeffel, X. Zhou, Y. Zheng, H. Ying, F. Lu, W.K. Stell, J. Qu, Effects of dopaminergic agents on progression of naturally occurring myopia in albino guinea pigs (Cavia porcellus), Invest Ophthalmol Vis Sci 55 (2014) 75087519.

ACCEPTED MANUSCRIPT

[23] M. Nebbioso, A.M. Plateroti, B. Pucci, N. Pescosolido, Role of the dopaminergic system in the development of myopia in children and adolescents, J Child Neurol 29 (2014) 1739-1746.

RI PT

[24] G.M. Seigel, W. Sun, J. Wang, D.H. Hershberger, L.M. Campbell, R.J. Salvi,

Neuronal gene expression and function in the growth-stimulated R28 retinal precursor cell line, Curr Eye Res 28 (2004) 257-269.

SC

[25] Z. Yang, Q. Zhang, J. Ge, Z. Tan, Protective effects of tetramethylpyrazine on rat retinal cell cultures, Neurochem Int 52 (2008) 1176-1187.

M AN U

[26] J. Li, Z. Dong, B. Liu, Y. Zhuo, X. Sun, Z. Yang, J. Ge, Z. Tan, Hypoxia induces beta-amyloid in association with death of RGC-5 cells in culture, Biochem Biophys Res Commun 410 (2011) 40-44.

[27] A.L. Dick, T. Pooters, S. Gibbs, E. Giles, A. Qama, A.J. Lawrence, J.R. Duncan,

TE D

NMDA receptor binding is reduced within mesocorticolimbic regions following chronic inhalation of toluene in adolescent rats, Brain Res 1624 (2015) 239-252. [28] P.E. Mann, Gene Expression Profiling during Pregnancy in Rat Brain Tissue, Brain

EP

Sci 4 (2014) 125-135.

[29] B. Mazurek, N. Amarjargal, H. Haupt, J. Fuchs, H. Olze, A. Machulik, J. Gross,

AC C

Expression of genes implicated in oxidative stress in the cochlea of newborn rats,

Hear Res 277 (2011) 54-60.

[30] M.W. Pfaffl, A new mathematical model for relative quantification in real-time RT– PCR, Nucleic Acids Research 29 (2001) 2002-2007.

ACCEPTED MANUSCRIPT

[31] Z. Tan, W. Qu, W. Tu, W. Liu, M. Baudry, S.S. Schreiber, p53 accumulation due to down-regulation of ubiquitin: relevance for neuronal apoptosis, Cell Death Differ 7 (2000) 675-681.

RI PT

[32] S. Ohngemach, G. Hagel, F. Schaeffel, Concentrations of biogenic amines in fundal layers in chickens with normal visual experience, deprivation, and after reserpine

AC C

EP

TE D

M AN U

SC

application, Vis Neurosci 14 (1997) 493-505.

ACCEPTED MANUSCRIPT

Figure legends Figure 1. Light exposures induce expression of dopamine D1 and D5 receptor transcripts in R28 cells. A). Conventional PCR shows differential induction of both

RI PT

DRD1 and DRD5 mRNA in R28 cells exposed to 10 lux or 500 lux light for 12 h. Schematic on the left shows the approximate positions of specific primers (arrows) listed in Table 1 and predicted sizes of PCR products. PCR from rat brain cDNA was

SC

used as a positive control for each receptor. Black arrows indicate the two predicted bands (317 bp and 404 bp) detected in cDNA from rat brain but not R28 cells. Empty

M AN U

arrow indicates no signal of GAPDH PCR product from genomic DNA in all samples. B). Melting curves of qPCR and agarose gel images of the qPCR products for DRD1 and DRD5.

TE D

Figure 2. Increased DRD1 immunoreactivity in R28 cells by light exposure. Immunofluorescence microscopy demonstrates weak DRD1 (red) staining in control cells (in dark) and markedly increased immunoactivity in cells after 12 h exposure to

EP

500 lux cool white light. Cell membrane is counterstained by wheat germ aggrelutinin

AC C

(WGA, green), while nuclei are stained with Hoechst 33342 (blue).

Figure 3. Changes in expression of both DRD1 and DRD5 transcripts in response to ambient lighting conditions. A). A diagram showing the different schedules for R28 cells exposed to 500 lux lighting and/or maintained in dark. B). qPCR results showing the relative abundance of DRD1 and DRD5 transcripts in R28 cells grown under

ACCEPTED MANUSCRIPT

different ambient lighting conditions. Bars are depicted as mean ± S.E.M.; *denotes p< 0.05.

RI PT

Figure 4. Dopamine and its antagonist differentially affect expression of DRD5 and/or DRD1 in R28 cells. qPCR analysis demonstrates that nanomolar scale

dopamine (A) inhibits expression of DRD1 and DRD5 and haloperidol (B) increases

SC

expression of DRD1 in R28 cells. Bars are depicted as mean ± S.E.M.; *denotes p<

AC C

EP

TE D

M AN U

0.05.

ACCEPTED MANUSCRIPT

Table 1. Primers and PCR conditions GenBank accession

Primer

number (target)

Forward:

NC_005116 (gDNA)

5’-TGACATCATGTGCTCTACGGC-3’ Reverse:

Forward: 5’-GCAGTCGAGCTTTCAGAGCC-3’

M35077 (cDNA)

303-323(F); 590-570 (R)

AC_000076 (gDNA)

56468-56487 (F); 59297-59277 (R)

M36831 (cDNA)

Reverse: 5’-TCTGCGGCTCATCGTCTTAAG-3’

X53278 (cDNA)

Forward:

Reverse: 5’-AGGAGTTCCGAGTCCTTTCCACG-3’ Forward:

Reverse: 5’-AGCCCAGCCAGGTGACAGCA-3’ Forward: DRD5

5’-GGAGGAAGGCTGGGAGCTAGAA-3’ Reverse: 5’-GCTGACACAAGGGAAGCCAGTC-3’ Forward:

GAPDH

54713-54735 (F); 58669-58647 (R)

×45''→ 57

size (bp)

94

×5'→ (94

×30'' →

72

×2') ×35 →72℃ ×5'→ 4℃

M84009 (cDNA)

717-740 (F); 1196-1177 (R)

594-615 (F); 996-975 (R)

NM_012768 (cDNA)

594-615 (F); 996-975 (R)

NC_005103 (gDNA)

3047-3066 (F); 3697-3678 (R)

2830

94℃×5'→ (94℃×30'' → 57℃×30'' → 404

72℃ ×1') ×35 → 72℃ ×5' → 4℃

317

95

×30''→ (95

→ 68

×20''→ 60.5

×20''

461

94 ×5' → (94 72

×30''→ 60

×30'' →

480

94

×5' → (94

×30'' → 60

×30'' →

72

×35'') ×35 →72℃ × 5'→ 4℃

→72℃ ×45'') ×35 → 72℃ ×5'→4℃

F, forward; R, reverse; bp, base pair.

403

403

Reverse: 520-539 (F); 971-952 (R)

672

×45'') ×35 →72℃ ×5'→ 4℃

94

AF106860 (cDNA)

3957

×30'') ×35→68℃×5'→ 4℃

5’-ACCACAGTCCATGCCATCAC-3’

5’-TCCACCACCCTGTTGCTGTA-3’

288

288

616-638 (F); 1075-1053 (R)

2303-2326 (F); 2974-2955 (R)

NC_005113 (gDNA)

Product

PCR condition

810-829 (F); 1126-1106 (R)

NC_005100 (gDNA)

EP

5’-TGCCCTGTCCGCTCATGCTACTGC-3’

AC C

DRD4

NM_017140 (cDNA)

809-828 (F); 1212-1192 (R)

TE D

DRD3

NC_005110 (gDNA)

5’-AGCATCTGCTCCATCTCCAACCC-3’

SC

5’-GAAATGGCATACGTCCTGCTC-3’

DRD2

1977-1997 (F); 2264-2244 (R)

M AN U

DRD1

Primer position

RI PT

Gene

×5' → (94

× 45'' → 56

× 45''

651

452

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT